1. Home
  2. AAM vs LAB Comparison

AAM vs LAB Comparison

Compare AAM & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAM
  • LAB
  • Stock Information
  • Founded
  • AAM 2024
  • LAB 1999
  • Country
  • AAM United States
  • LAB United States
  • Employees
  • AAM N/A
  • LAB N/A
  • Industry
  • AAM
  • LAB Biotechnology: Laboratory Analytical Instruments
  • Sector
  • AAM
  • LAB Industrials
  • Exchange
  • AAM Nasdaq
  • LAB Nasdaq
  • Market Cap
  • AAM 460.0M
  • LAB 504.2M
  • IPO Year
  • AAM 2024
  • LAB 2011
  • Fundamental
  • Price
  • AAM $10.55
  • LAB $1.27
  • Analyst Decision
  • AAM
  • LAB Buy
  • Analyst Count
  • AAM 0
  • LAB 2
  • Target Price
  • AAM N/A
  • LAB $2.50
  • AVG Volume (30 Days)
  • AAM 3.6K
  • LAB 1.6M
  • Earning Date
  • AAM 01-01-0001
  • LAB 11-04-2025
  • Dividend Yield
  • AAM N/A
  • LAB N/A
  • EPS Growth
  • AAM N/A
  • LAB N/A
  • EPS
  • AAM 0.32
  • LAB N/A
  • Revenue
  • AAM N/A
  • LAB $172,271,000.00
  • Revenue This Year
  • AAM N/A
  • LAB N/A
  • Revenue Next Year
  • AAM N/A
  • LAB N/A
  • P/E Ratio
  • AAM $32.82
  • LAB N/A
  • Revenue Growth
  • AAM N/A
  • LAB 76.33
  • 52 Week Low
  • AAM $10.02
  • LAB $0.92
  • 52 Week High
  • AAM $10.79
  • LAB $2.32
  • Technical
  • Relative Strength Index (RSI)
  • AAM 60.59
  • LAB 45.49
  • Support Level
  • AAM $10.55
  • LAB $1.26
  • Resistance Level
  • AAM $10.60
  • LAB $1.44
  • Average True Range (ATR)
  • AAM 0.02
  • LAB 0.09
  • MACD
  • AAM 0.00
  • LAB -0.00
  • Stochastic Oscillator
  • AAM 62.50
  • LAB 12.51

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: